Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evolving concepts in myelodysplastic syndromes.

A Raza1

  • 1MDS Center, Section of Myeloid Diseases, Department of Medicine, Rush University, Chicago, IL, USA.

Cancer Treatment and Research
|November 13, 2001
PubMed
Summary

Myelodysplastic syndromes (MDS) are complex blood disorders requiring personalized care. While stem cell transplants offer a cure, ongoing research into MDS biology is crucial for developing new treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transient Large-Scale Anisotropy in TeV Cosmic Rays due to an Interplanetary Coronal Mass Ejection.

Physical review letters·2026
Same author

First Detection of Ultrahigh Energy Emission from Gamma-Ray Binary LS I +61° 303.

Physical review letters·2026
Same author

Evidence of Cosmic-Ray Acceleration up to Sub-PeV Energies in the Supernova Remnant IC 443.

Physical review letters·2026
Same author

Precise Measurement of the Cosmic Ray Helium Spectrum above 0.1 PeV.

Physical review letters·2026
Same author

A REVIEW OF CURRENT CONCEPTS IN THE MANAGEMENT OF BONE DEFECTS IN TRAUMA AND ORTHOPAEDICS.

Georgian medical news·2025
Same author

All-Sky Search for Individual Primordial Black Hole Bursts with LHAASO.

Physical review letters·2025

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Myelodysplastic syndromes (MDS) are a diverse group of clonal hematopoietic stem cell disorders.
  • MDS are characterized by ineffective hematopoiesis and are associated with an increased risk of transformation to acute myeloid leukemia.
  • The heterogeneity of MDS necessitates individualized treatment approaches.

Purpose of the Study:

  • To highlight the complex nature of myelodysplastic syndromes.
  • To emphasize the need for specialized care and clinical trials for MDS patients.
  • To underscore the importance of understanding MDS biology for therapeutic advancement.

Main Methods:

  • Review of current understanding of MDS pathogenesis.
  • Analysis of recent advancements in MDS treatment options.
  • Discussion of the role of specialized centers and experimental protocols.

Main Results:

  • MDS represent a heterogeneous group of disorders with no single etiology or treatment.
  • Expanded therapeutic options are available due to recent biologic insights.
  • Stem cell transplantation remains the only curative therapy currently.

Conclusions:

  • MDS management requires a patient-centered approach, offering all therapeutic choices, including watchful waiting.
  • Continued research into MDS biology and etiology is essential for significant therapeutic progress.
  • Maintaining momentum in MDS research is critical for future advancements.

Related Experiment Videos